BioDuro and Cenra launch joint venture to expand resilient global API manufacturing capacity: Irvine Californa Thursday, March 5, 2026, 14:00 Hrs [IST] BioDuro, a globally trusted ...

ESTEVE CDMO, a global CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, began a $15.5 ...

The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...

(MENAFN- GlobeNewsWire - Nasdaq) 40%-50% of New Cancer Drugs are High-Potency APIs: Unlocking Opportunities for Specialized CMOs Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "High Potency API ...

The MarketWatch News Department was not involved in the creation of this content. The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031.

Outsource API manufacturing to India for lower costs, GMP-compliant quality, scalable production, and faster time-to-market for pharma companies.

Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "High Potency API Contract Manufacturing Market by Product, Synthesis, Application, Dosage Form, End User and Region" report has been added to ...

The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031. Demand for biologics, biosimilars, and other biopharmaceuticals is growing at a ...

(MENAFN- IMARC Group) An API (Active Pharmaceutical Ingredient) is the biologically active component of a drug that produces the intended therapeutic effect. It is the essential substance in medicines ...